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Abstract
Objective: The aim of the present report is to present a systematic and critical review of the more recent literature data about structural 
abnormalities detected by magnetic ressonance in anxiety disorders. Method: A review of the literature in the last five years was conducted 
by a search of the Medline, Lilacs and SciELO indexing services using the following key words: “anxiety”, “panic”, “agoraphobia”, 
“social anxiety”, “posttraumatic” and “obsessive-compulsive”, crossed one by one with “magnetic resonance”, “voxel-based”, “ROI” and 
“morphometry”. Results: We selected 134 articles and 41 of them were included in our review. Recent studies have shown significant 
morphological abnormalities in various brain regions of patients with anxiety disorders and healthy controls. Despite some apparently 
contradictory findings, perhaps reflecting the variability and limitations of the methodologies used, certain brain regions appear to 
be altered in a consistent and relatively specific manner in some anxiety disorders. These include the hippocampus and the anterior 
cingulate cortex in posttraumatic stress disorder and the orbitofrontal cortex in obsessive-compulsive disorder. Conclusions: The present 
review indicates that structural neuroimaging has contributed to a better understanding of the neurobiology of anxiety disorders. Further 
development of neuroimaging techniques, better sample standardization and the integration of data across neuroimaging modalities 
may extend progress in this area.
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Resumo
Objetivo: Apresentar uma revisão sistemática e crítica dos achados mais recentes da literatura em relação a alterações estruturais avaliados 
por ressonância magnética nos transtornos de ansiedade. Método: Uma revisão da literatura dos últimos cinco anos foi realizada utilizando 
uma busca nos indexadores Medline, Lilacs e SciELO utilizando as seguintes palavras-chave: “anxiety”, “panic”, “agoraphobia”, “social anxiety”, 
“posttraumatic” e “obsessive-compulsive” cruzadas uma a uma com “magnetic ressonance”, “voxel-based”, “ROI” e “morphometry”. 
Resultados: Foram selecionados 134 artigos, sendo 41 foram incluídos nesta revisão. Estudos recentes mostram alterações morfológicas 
significativas entre os pacientes com transtorno de ansiedade e os controles saudáveis em várias regiões cerebrais. Apesar de achados 
contraditórios, sobretudo devido à variabilidade e às limitações nas metodologias utilizadas, algumas estruturas aparecem alteradas 
de forma mais consistente e relativamente específica em alguns transtornos de ansiedade, como o hipocampo e o córtex cingulado 
anterior no transtorno de estresse pós-traumático e o córtex orbitofrontal no transtorno obsessivo-compulsivo. Conclusões: A presente 
revisão aponta que a neuroimagem estrutural pode ser utilizada na busca de uma maior compreensão da neurobiologia dos transtornos 
de ansiedade. É possível que o rápido avanço das técnicas de neuroimagem, uma maior padronização das amostras e a associação de 
dados de diferentes modalidades permitam um maior entendimento deste cenário.
Descritores: Ansiedade; Imagem por ressonância magnética; Processamento de Imagem assistida por computador; Tomografia com-
putadorizada volumétrica; Modelos estruturais
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Introduction 
The diagnostic classification of anxiety disorders has occurred 
relatively late within the history of mental disorders. This is mainly 
due to the fact that the various disorders currently referred to as 
anxious were not even recognized as belonging to the same entity. 
In the recent past, this group of disorders was thought to be of a 
purely psychological nature. However, current studies have raised 
new hypotheses linking biological components to the etiology and 
specific symptoms of these disorders.1
The framework considered as the most helpful to the understanding 
of the physiological and behavioral characteristics of anxiety disorders 
is the fear conditioning model, widely studied in animals over 
several decades.2 In a typical fear conditioning paradigm, learned 
associations generally involve presentation of a neutral stimulus 
such as a tone and may include lesions or stimulation of different 
brain regions. It should be noted that not all anxiety disorders in 
humans necessarily arise as a consequence of learned associations; 
in fact, by definition, only Posttraumatic Stress Disorder (PTSD) is 
known to arise in the aftermath of an emotionally traumatic event.3 
Nevertheless, some aspects of the fear conditioning model may 
indeed be relevant to all forms of pathological anxiety, and much 
has been learned about the neural circuitry of fear and anxiety from 
animal models.4,5 
Based on the fear conditioning framework, anxiety disorders are 
believed to arise out of some abnormality in cortical/subcortical 
interactions, resulting in an inappropriate expression of the fear 
response.6 Clearly, the amygdala plays a critical role in the functional 
neurocircuitry of anxiety disorders. This brain area mediates states 
of increased arousal as well as the fear response, and its central 
nucleus serves as the hub for the integration of information and 
for the execution of autonomic and behavioral fear responses. 
Connections between the amygdala and the sensory thalamus, 
prefrontal, insular, and somatosensory cortices are relevant in 
recognizing threat-related information. For instance, the insular 
cortex seems to be important for subjective feeling states and 
interoceptive awareness. In addition, other two key brain areas 
appear to be important to the understanding of anxiety disorders. 
The hippocampus has been suggested to be involved in processing 
of contextual information. Dysfunction of this brain area has been 
related in the pathological anxiety via overgeneralization, as a 
consequence of deficient appreciation for the contextual specificity 
of potentially threatening stimuli. Moreover, the medial frontal 
cortex in general and the anterior cingulate gyrus in particular, are 
important for cognitive and affective aspects of conflict as well as 
for the emotional processing and executive control in response to 
environmental demands. These neural substrates with executive 
function modulate the activation of the amygdala and the extended 
limbic system.3
Distinctions between the neural circuitry underlying different 
anxiety disorders have been hypothesized on the basis of animal and 
pharmacological studies, as well as clinical observation. PTSD, for 
example, provides perhaps the best example of an anxiety disorder 
which appears to follow the classical fear conditioning model. 
The hyper-responsivity of the amygdala to threat-related stimuli 
is perhaps exacerbated due to inadequate top-down modulation 
by the ventromedial prefrontal cortex and the hippocampus.7 
Abnormalities in the ventromedial prefrontal cortex may interfere 
with impaired extinction of the fear response and executive control 
to threat-related stimuli. Additionally, hippocampal dysfunction may 
underlie the overgeneralization of fear responding and concurrent 
impairment of explicit memory.8 On the contrary, the main theories 
of Obsessive-Compulsive Disorder (OCD) do not emphasize a major 
role for the amygdala, since considerable evidence implicates the 
cortico-striatal circuitry in the pathophysiology of this psychiatric 
condition. The striatum has been implicated in mediating motor 
activities and diverse cognitive and affective functions, such as 
repetitive, stereotyped cognitive processes on an implicit level.3
Apart from the above cited animal studies and clinical observations, 
the research area that has contributed most significantly to bring new 
insights onto the commonalities and differences between the anxiety 
disorders and their respective neural circuitries is neuroimaging. 
Brain imaging techniques allows the in vivo evaluation of the 
human brain, allowing a better understanding of its anatomical, 
functional and metabolic substrate. Among the various neuroimaging 
methods used, magnetic resonance imaging (MRI) is one of the most 
frequently employed mainly because of its high image resolution 
and the ability in providing distinction between different tissues, in 
addition to being harmless to the patient. These images can provide 
diverse qualitative and quantitative information about the cerebral 
structure of the patient.
One of the well-accepted methods used for the investigation of 
brain morphometry involves the use of regions of interest (ROI). 
In its most conventional form, the ROI-based approach requires 
manual delineation of cerebral regions in sequential MRI slices, 
and the areas obtained in each slice are summed up to provide a 
measure of the volume of the brain structure of interest. In order to 
minimize observer biases, landmarks and rules for manual tracing 
must be defined a priori, and operators must be rigorously trained. 
The procedure is laborious, thus limiting the number of brain 
regions analyzed and the sample size, also requiring investigators 
to have an a priori hypothesis regarding specific brain regions.9 
Furthermore, ROI-based studies are limited in their treatment 
of neocortical morphology because of the inherent difficulties in 
defining structurally complex and variable regions of the human 
cortex. The systematic morphometry evaluation of the brain as a 
whole has recently become possible with the use of automated 
techniques of voxel-by-voxel analysis.10 Such voxel-wise methods 
originate from the automated methods developed in the 1990 
decade for the analysis of Positron Emission Tomography (PET) data, 
most often using a program named Statistical Parametric Mapping 
(SPM). The application of such methodology to structural MRI, 
named Voxel-Based Morphometry (VBM), allows the comparison 
of the concentration/volume of the gray and white matter between 
groups of interest for each voxel of the cerebral volume after 
automatic image segmentation, without the need to define ROI 
margins in advance.11 Structural MRI scans are spatially normalized 
to an anatomical template and segmented into gray matter, white 
matter, and cerebrospinal fluid (CSF) compartments.11 In optimized 
versions, the VBM methodology allows the creation of study-specific 
templates that average MRI scans acquired with the same equipment 
and imaging parameters.12 Processing steps have been added to 
minimize the influence of extra-cerebral voxels on the routines 
of spatial normalization and segmentation, and to preserve the 
volumes of brain structures, which may be considerably deformed 
during normalization.12 Our previous review,10 focused on general 
neuroimaging alterations in anxiety disorders, identified some 
significant neuroanatomical findings. These included a relevant 
role attributed to alterations in the orbitofrontal-striatal-thalamic 
circuits in OCD, abnormalities in the temporal lobe of patients 
with Panic Disorder (PD) – although not often reproduced –, and 
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reductions in the volume of the hippocampus, corpus callosum and 
total brain in patients with PTSD. That review10 also highlighted the 
substantial contradictions of findings across different studies, which 
were attributable, overall, to the variability and limitations in the 
methodologies adopted. The scarceness of studies on Generalized 
Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and specific 
phobias was also noteworthy.
Since the publication of the above review of neuroimaging findings 
in anxiety disorders,10 a large number of important new studies have 
been published. At that time, many of the comments we offered were 
tentative, due to an insufficient amount of research studies available 
for some anxiety disorders. Results of the more recent investigations 
allow us to comment on structural MRI in such conditions with a 
greater degree of confidence.
To spare readers the burden of reviewing the earlier manuscript as 
a prelude to this update (a chapter of a book published in Portuguese 
and not generally available), we begin each section of the current 
report by briefly summarizing our earlier observations.
In the present study we reviewed articles published in the last 
five years, which used MRI for morphometric evaluation of the 
brain in studies related to anxiety disorders, with emphasis on the 
structural findings obtained and the different methodologies used, 
thus expanding our previous review.
Objectives
Neuroimaging can help elucidate the biological processes 
that occur in brain regions related to psychological experiences 
manifested in psychiatric disorders. The present report aims to 
present a systematic qualitative review of the more recent literature 
findings related to structural abnormalities obtained by MRI for each 
diagnostic category of anxiety disorders.
We chose this approach rather than using meta-analysis for 
several reasons: 1) the  information needed to compute effect 
size was not always available and could limit our analysis to a 
small subset of studies; 2) the methods and extent of detailed 
information to define ROI varies widely in the studies, preventing 
accurate comparison; 3) there is a large difference in secondary 
variables across studies (i.e. gender, medication, co-morbidities); 4) 
very few MRI studies are available for some disorders, hampering 
quantitative analyses; 5) meta-analysis has intrinsic limitations in 
estimating negative findings that do not get published, i.e. the ‘file 
drawer’ problem. Therefore, a meta-analytic approach may not be 
appropriate for a review of this broad scope, which covers more 
than one specific anxiety disorder.
Finally, it is well known that MRI imaging techniques in animal 
research can also contribute to the investigation of anxiety disorders.1 
However, we decided to focus on human studies because we believe 
that the integration of animal and human data would be beyond 
the scope of the present review.
Method
A search was conducted in the Medline, Lilacs and SciELO 
indexing services using the following keywords: “anxiety”, “panic”, 
“agoraphobia”, “social anxiety”, “posttraumatic” and “obsessive-
compulsive” crossed one by one with “magnetic resonance”, 
“voxel-based”, “ROI” and “morphometry”. We selected 134 articles 
that were filtered through an inspection of the abstracts in order to 
include only publications dealing with human samples and using 
the case-control experimental design. Thirty-one review studies 
and 11 case reports were excluded. The final selection included 
41 papers published from January 2003 to December 2007, 
including articles published in the last five years after our previous 
review. The references of the selected articles were also consulted 
for additional citations.
Results
Of the 41 articles selected for the present review, 23 dealt 
with PTSD, 11 with OCD, seven with PD, and one with GAD. 
Morphological brain abnormalities were evaluated in each study, 
and only four of them13-14 have detected no significant differences 
between the patient and control groups.  
1. Posttraumatic stress disorder (PTSD)
PTSD is a psychiatric condition developed by some individuals 
after exposure to emotionally severe traumatic events such as 
childhood abuse, war traumas, and natural accidents, among 
others.15 The most common symptoms are a persistent re-experience 
of the traumatic event, blunted general responsiveness, increased 
excitation, and avoidance of stimuli associated with the traumatic 
event. In addition to these symptoms, patients with this disorder 
usually present cognitive dysfunction linked to declarative memory, 
learning and attention.16  
Most MRI studies in the literature to date have focused on 
volumetric differences between groups regarding the hippocampus. 
This choice is based on the evidence that the hippocampus is 
critical to mnemonic processing, as well as on the assumption 
that this brain structure is involved in the pathogenesis of the 
symptoms of persistent re-experience of the traumatic event.17-20 
Hippocampal abnormalities in association with PTSD may represent 
pre-trauma vulnerability to the development of the disorder or may 
be the consequence of exposure to trauma, of PTSD or even of 
comorbidities associated with the disorder.21
The morphometric MRI studies of PTSD discussed in our previous 
review10 showed important disagreement in respect to hippocampal 
volume, having some studies reported volumetric reduction and 
others indicated absence of alterations in this brain region. Patients 
with PTSD also presented reduced total brain volume, reduction in 
the corpus callosum, and ventricular enlargement. Studies focusing 
on the amygdala, caudate and temporal lobe up until then had not 
found differences between PTSD patients and controls. 
Studies published in the last five years have, in their majority, 
reinforced our earlier observation17-20 that there may be significant 
hippocampal volume reductions in PTSD sufferers compared to 
controls.22-27 However, as shown in our previous review,10 there is 
also some disagreement about laterality21,28-30 and even about the 
presence of this reduction,13,31-34 in both ROI and VBM-based studies. 
These contrasting findings, in addition to being due to possible 
neurobiological abnormalities, may also be due to methodological 
limitations such as differences in the selection of the hippocampus 
by manual methods. Bremner et al.,22 for example, only traced the 
middle portion of this structure, while other studies measured the 
hippocampus as a whole.31,33 Another hypothesis is that changes 
in the hippocampus may be so subtle that they would not always 
be detectable by the standard procedure based on MRI.29
Other interesting data are related to the effect of treatment on 
hippocampal volume. While a clinical study using paroxetine 
demonstrated an increase in hippocampal volume in 23 patients 
with PTSD and improvement of declarative memory after treatment,35 
another study did not reveal any volumetric changes in a group of 
PTSD patients investigated before and after effective psychotherapy 
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treatment.24 Of note, these contradictory findings may be attributed 
to differences in the methods of brain volumetric assessment, since 
the first study35 used VBM, while the second24 used the manual, 
ROI-based approach.
The first morphometric MRI study using automated, voxel-based 
analysis methods in PTSD36 detected reduction of the left anterior 
cingulate cortex, a region not predicted a priori in previous studies 
using manual analysis methods. Several studies later confirmed a 
volumetric reduction of the anterior cingulate cortex in association 
with PTSD, although there has been disagreement regarding 
laterality since differences were detected in the right37 and left29 
pregenual region21 and in the anterior cingulated region as a whole.37 
Of particular interest is the fact that the anterior cingulate cortex has 
close neuroanatomical relations with subcortical components of the 
“central fear system”, including the amygdala and locus coeruleus. 
If the anterior cingulate cortex actually exerts an inhibitory regulation 
of the amygdala, then the attenuation of this regulation may explain 
the multiple symptoms of PTSD.8,37
The insula, another region functionally related to the amygdala, 
has been found to be repeatedly reduced in volume in PTSD patients 
in recent voxel-based morphometric studies.21,29,38 There is evidence 
indicating that the insula is involved both in emotional processing 
and in cognition, with connections linked to the prefrontal cortex, 
limbic system and temporal pole.39 In a meta-analysis of 43 studies 
using PET and of 12 studies using functional MRI (fMRI), Phan et 
al. suggested that the anterior cingulate cortex and the insula may 
be involved in emotional induction in association with cognitive 
demands.40 On this basis, these regions may be involved both in 
the cognitive and emotional processing deficits observed in patients 
with PTSD. In particular, the insular cortex has been associated with 
increased bilateral activation in memory processing tests,41-42 being 
memory deficits prominent characteristics of PTSD.
PTSD in abused children is a complex scenario, with findings 
of reduced volume of the brain and of the mediosagittal area of 
the corpus callosum and of increased lateral ventricle.43 The same 
research group, which was the first to examine the cerebellum by 
a manual method, later detected a reduction of cerebellar volume 
in children and adolescents with PTSD.44 In view of previous 
findings of an increased corticotropin concentration in adults and 
children with PTSD,45 a study on a pediatric population focused 
on the pituitary gland but the authors did not find any significant 
difference between patients and controls.46
In general, the diversity of traumatic events, the chronicity of PTSD 
and the presence of co-morbidities contribute to the heterogeneity of 
population samples, impairing the comparability and generalization 
of the results. Also, some studies used only men, others used only 
women, whereas still others used equal gender proportions, but 
without major care in balancing the samples (see Table 1). There 
is also wide variation in the mean ages of the participants in these 
studies due to the fact that some studies were conducted on pediatric 
patients and others on war survivors.
2. Obsessive-compulsive disorder (OCD)
OCD is a psychiatric disorder whose major characteristic is the 
presence of recurrent and intrusive thoughts (obsessions) and/or 
voluntary repetitive acts (compulsions).47 
As is the case for other anxiety disorders, the neurobiology of 
OCD has not been fully established but, together with PTSD, this 
disorder has been extensively investigated over the last decades. 
The dominant neurobiological model postulates that abnormalities 
in the orbitofrontal-striatal-thalamic circuits may be involved in the 
pathophysiology of OCD.48 Dysfunctions in these circuits may be 
associated with implicit processing deficit and intrusive symptoms.9 
In our previous review,10 most of the ROI-based morphometric MRI 
studies were focused on basal ganglia regions, with positive findings 
in the caudate nucleus, putamen, globus pallidus, and striatal 
region. In addition, VBM studies analyzing the brain as a whole 
have suggested that it is possible to identify alterations in regions 
not restricted to the basal ganglia, giving support to the notion that 
different portions of the segregated corticostriatal circuits may be 
distinctly involved in the physiopathology of OCD.
In recent studies using the manual ROI-based approach, the most 
consistent findings are a reduction in the volume of the orbitofrontal 
cortex, at times on the left side,49-50 and at others bilaterally.51-52 
On the other hand, two recent studies that used VBM reported 
contrasting results. Pujol et al.53 showed a reduction in volume of 
the medial orbitofrontal cortex whereas other study54 observed an 
increase of the posterior orbitofrontal region. There was also a study 
using both ROI-based and automatic, voxel-based methods that did 
not detect significant differences in this cerebral region between 
patients with OCD and controls.55 
A factor that may have contributed to the conflicting results is 
the presence of drug treatment. However, the studies on drug-naïve 
patients have also obtained contrasting results. In a study on 23 
pediatric patients with a diagnosis of OCD but with no previous 
treatment, a smaller volume of the globus pallidus and a greater 
volume of the anterior cingulate cortex were detected compared to 
26 healthy controls using semi-automated, ROI-based methods.56 
A greater volume of the pituitary gland was also detected using 
the manual ROI method in untreated pediatric patients with OCD, 
being more prominent among boys.57 A recent study using the ROI-
based approach on a sample of never-medicated adults detected 
a reduced volume of the right and left orbitofrontal cortex and a 
greater volume of the thalamus, also bilaterally.52 A previous study 
by the same group had associated these regions with refractoriness 
to the treatment of OCD.51
The efficacy of selective serotonin re-uptake inhibitors (SSRIs) in 
controlling obsessive-compulsive symptoms strongly suggests the 
involvement of abnormalities of serotoninergic transmission in the 
pathophysiology of OCD.9,58 Szesko et al. monitored 11 children with 
a diagnosis of OCD before and after treatment with paroxetine and 
demonstrated that, in addition to these patients having asymmetry 
of the amygdala before treatment (the left one larger than the right 
one), their left amygdala volume was reduced after the use of this 
SSRI in a study using a semi-automated ROI-based method.59 
Serotoninergic transmission in this brain area has been associated 
with the modulation of fear and of conditioned anxiety, factors that 
seem to play an important role in OCD.59
Other limbic structures have been evaluated in the various 
morphometric MRI studies of OCD, having been detected 
inconsistencies in volumetric changes, such as an increase56 
and a reduction of the cingulate cortex,54,60 an increase of the 
temporolimbic cortex and of the insula,54 and a reduction of the 
insulo-opercular region.53 Reduction of the white and gray matter in 
the right parietal cortex was also found,54,60 an area not previously 
investigated in structural studies by ROI, but which had already 
shown lower activity in studies of functional neuroimaging.61
As observed above in the studies on PTSD, there was considerable 
sample heterogeneity regarding sex, age, presence of comorbidities 
and subtypes of the disorder in the morphometric MRI studies of 
Rev Bras Psiquiatr. 2008;30(3):251-64
Ferrari MCF et al.255
Structural MRI in anxiety disorders
Rev Bras Psiquiatr. 2008;30(3):251-64
256
Rev Bras Psiquiatr. 2008;30(3):251-64
Ferrari MCF et al.257
Structural MRI in anxiety disorders
Rev Bras Psiquiatr. 2008;30(3):251-64
258
OCD to date (Table 2). In particular, populations of varied age ranges 
have been studied. There is evidence of a correlation between 
greater widening of striatal structures with age,53 and no structural 
abnormalities of these regions have been detected in children.56,60
3. Panic disorder (PD)
PD is characterized by the occurrence of unexpected panic attacks 
with consequent anticipatory anxiety about experiencing new 
episodes. The manifestations of PD include a variety of affective, 
cognitive, behavioral and physiological symptoms. Due to the nature 
of the symptoms, subcortical areas such as basal ganglia and limbic 
system have been suggested to be involved in the pathophysiology 
of PD.62-63 In our previous review,10 abnormalities of the basal 
ganglia were not reported, whereas a reduced volume of areas of 
the temporal lobe was described.64-66 However, functional imaging 
studies during rest have previously revealed abnormal activity in the 
hippocampus and in other limbic structures such as the amygdala 
and cingulated gyrus.63
Massana et al. evaluated the amygdala, temporal lobe and 
hippocampus of 12 patients with PD compared to 12 healthy 
controls.67 This was the first study to determine the volume of 
the amygdala in PD patients, with the observation of a significant 
bilateral reduction of this region compared to controls. Later, Uchida 
et al., using the same a priori hypothesis, detected a reduction 
of the left temporal lobe in 11 patients with PD compared to 11 
controls.68 
The absence of abnormalities of the temporal lobe in the study by 
Massana et al.67 in contrast to the study by Uchida68 and to previous 
literature66 may be attributed to a highly conservative measurement 
of the ROI, centered only on the medial segment and excluding the 
volumes of the hippocampus and amygdala. 
In another direction, there is the hypothesis that structures of the 
septo-hippocampal system may be associated with PD symptoms 
since this region seems to play a crucial role in the modulation of 
anxiety.69 Supporting this notion, another study detected a high 
frequency of cavum septi pellucidum (CSP) in patients with PD 
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who presented EEG abnormalities.70 More recently, Crippa et al.14 
investigated the prevalence and size of the CSP in 21 PD patients 
compared to 21 healthy controls, but no significant differences were 
detected between groups by manual, ROI-based methods.
The first study on PD patients using VBM-based methods 
detected a reduction of gray matter in the left parahippocampal 
gyrus of PD patients.71 Later, other study,72 using optimized VBM 
demonstrated a bilateral reduction of gray matter in the putamen 
of 18 patients with PD compared to healthy controls. In the cited 
study, the severity of PD symptoms and the duration of the disorder 
were negatively correlated with the volume of the putamen. More 
recently, Protopopescu et al., also using optimized VBM, detected 
an increased gray mass volume in the brain stem of 10 patients 
with PD compared to controls, specifically at rostral sites.73
More recently, Uchida et al. assessed gray matter volume in 19 
PD patients and 20 healthy volunteers using VBM.74 The authors 
found relative increase in gray matter volume in the left insula of PD 
patients as compared to controls. Moreover, it was also observed in 
the PD group increases in the left superior temporal gyrus as well as 
in the midbrain and pons. Relative gray matter deficit occurred in the 
right anterior cingulate cortex. The authors concluded that insula and 
anterior cingulate abnormalities may be relevant to the evaluation 
process that ascribes negative emotional meaning to potentially 
distressing cognitive and interoceptive sensory information in PD 
and that the abnormalities in brain stem structures may be involved 
in the generation of panic attacks.
The PD and control groups of the above studies were matched 
for number, age, years of schooling, socioeconomic level and hand 
dominance. Small samples were investigated in all of these studies, 
ranging from 10 to 21 patients with PD. However, the studies 
mainly differed regarding the use of psychotropic medication and 
the presence of comorbidities (Table 3).
4. Generalized anxiety disorder (GAD)
GAD is a chronic and recurrent disorder characterized by excessive, 
pervasive and uncontrollable concern. Associated symptoms include 
irritability, restlessness and concentration impairment. Somatic 
symptoms may include muscle tension, sweating, dry mouth, 
nausea and diarrhea.75 The prevalence of GAD is considered high 
in the general population, and the symptoms closely resemble those 
of other anxiety disorders. This has led some investigators to contest 
it as a distinct diagnostic category. 
Neurobiological studies using different investigative techniques 
(e.g. neurochemistry, physiology and genetics) in both humans and 
animals have indicated that, in GAD, there may be abnormalities of 
some brain regions responsible for emotional processing and social 
behaviors, such as the amygdala, prefrontal cortex and temporal 
areas.76 As previously observed, few studies using structural 
volumetric MRI are available for this disorder, a fact that prevents 
definitive conclusions based on volumetric data.77-78 In our former 
review10 the few morphometric MRI studies available up until then 
supported the hypotheses raised by investigations using other tools, 
such as functional neuroimaging,79 which postulated the presence of 
anatomical abnormalities localized in the amygdala and the temporal 
lobe, more specifically the superior temporal gyrus, in association 
with the diagnosis of GAD.77-78
One of the recent morphometric MRI studies of GAD used the 
VBM-based approach to compare children with and without anxiety. 
The sample of patients with anxiety was heterogeneous, consisting 
of 9 patients with social anxiety disorder, 3 with separation anxiety, 
and 13 with a diagnosis of GAD. Reduction of the volume of the 
left amygdala was demonstrated in the group of patients with 
anxiety, this being a region commonly implicated in the mediation 
of emotional responses.80 However, the heterogeneity of anxiety 
disorders limits the specificity of the findings.
Discussion
Given that we have only begun to understand the neural circuitry 
of anxiety, our current diagnostic classification system of the 
anxiety disorders is arguably not the most effective tool available. 
Evidence from treatment and neuroimaging studies strongly indicate 
that the anxiety disorders that are currently classified in separate 
diagnostic categories may have overlapping pathology, while 
those that are grouped together within a given category may have 
very different underlying brain mechanisms. Ongoing efforts in 
neuroimaging promise to elicit new insights into the commonalities 
and differences among the anxiety disorders and their respective 
neural circuitries.81
In this updated review of morphometric MRI studies of anxiety 
disorders, we have once again verified that PTSD remains as 
the anxiety disorder most extensively investigated by structural 
neuroimaging over the last five years. In agreement with our previous 
review,10 the main morphological feature detected in this disorder 
is a reduction of the hippocampus,22-27 although with some degree 
of disagreement among studies regarding laterality and even the 
presence of changes. 
In some studies using manual ROI-based methods, the 
investigators looked for associations between clinical data and 
hippocampal changes, as was the case for the negative correlation 
detected between re-experiencing the traumatic event and the 
hippocampal volume.23 The fact that reduced volume of this 
structure is already detectable in patients with PTSD examined 
shortly after the traumatic event28 supports the hypothesis that 
reduction of the hippocampus may be a predisposing factor for 
the development of PTSD (rather than a consequence of PTSD 
symptoms). 
On the other hand, the presence of hippocampal reduction 
detected in traumatized burn patients without PTSD suggests 
that this morphological change may be associated with trauma in 
general, rather than being specifically related to the development of 
PTSD.26 In agreement with this possibility, a recent ROI-based MRI 
study found an increase of the lateral temporal lobe and superior 
temporal gyrus in survivors of the Holocaust with and without PTSD 
compared to healthy controls.33
Most MRI studies of PTSD to date used ROI-based methods, at 
times with significant divergence regarding the a priori hypotheses 
across studies, with different findings such as reduction of the 
corpus callosum and cerebellum and increase of the lateral ventricle, 
superior temporal gyrus and temporal lobe. Since the introduction 
of automated VBM-based techniques for the investigation of this 
disorder, findings in brain areas not previously investigated by the 
ROI-based methods have been reported in several studies, such 
as bilateral reduction of the insula and of the anterior cingulate 
cortex.21,29,30,33,36,37 The anterior cingulate gyrus is considered to have 
a key role in emotional and cognitive associations in respect to fear 
and anxiety. Lesions of this brain area have been shown to induce 
emotional reactions and impair behavioral extinction, seemingly 
because they disrupt the inhibitory influence of the prefrontal 
cortex on the amygdala.3 Therefore, the volumetric reduction of 
the anterior cingulate cortex is in agreement with the PTSD model 
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related to the neural circuitry of conditioned fear, being amygdala 
hyperresponsivity in face of deficits in the cortical components 
responsible for its regulation.
In general, functional neuroimaging studies conducted on OCD 
over more than two decades using PET, Single Photon Emition 
Computed Tomography (SPECT), fMRI and spectroscopy have 
confirmed the notion that abnormalities of the orbitofrontal-striatal-
thalamic circuits are of critical importance for the pathophysiology 
of this disorder.9 In the present review, structural abnormalities 
have also been frequently identified in regions of this circuit such 
as the orbitofrontal cortex,49-54 although in disagreement from 
the laterality and direction of the abnormality. Other significant 
abnormalities have been reported for the basal ganglia, thalamus, 
insula, cingulate cortex and amygdala, although the results reported 
are also discrepant among the various studies.51-54,56,60 Variations in 
the nature of the sample or of the volumetric methods may explain 
such discordances between studies. Regarding OCD, there is also 
evidence that specific morphological abnormalities may be related 
to the stage of the disease and to the different clinical subtypes of 
this disorder, with important implications for the search for new 
treatment strategies.
Valente et al. using the VBM methodology, obtained different 
results for the volume of separate portions of the orbitofrontal cortex 
depending on the severity of OCD symptoms, even after exclusion 
of depression as a comorbidity.54 These results are consistent 
with the idea that the orbitofrontal cortex presents heterogeneous 
functional subdivisions, each possibly playing a different role in the 
pathophysiology of the various symptoms of OCD.82 Additionally, 
other brain regions may also be associated with different 
symptomatologic dimensions in OCD. For example, in one study 
using VBM,53 patients with aggressive obsessions and compulsions 
showed reduced amygdala volume in the right hemisphere. 
Additionally, reduction of the pituitary gland was associated with the 
severity of compulsive symptoms, but not of obsessive symptoms.57 
These findings partially challenge previous models that associate 
obsessive symptoms with increased frontal cortex activity, and 
compulsive symptoms with striatal abnormalities.3
Although structures of the corticostriatal circuitry are classically 
implicated in the pathophysiology of OCD, the observation of 
increased amygdala volume following treatment described in the 
present review supports a proposition that this temporolimbic 
structure may also be of critical relevance to OCD. Amygdala 
abnormalities have been described in a previous functional study9 
which found a significant correlation between the activation of 
this brain area and symptom increase in OCD. Given the intimate 
connections between the amygdala and the striatum, their 
anatomical proximity and respective roles, it has been suggested 
that activation of the amygdala during a state of fear or anxiety could 
promptly induce stereotyped behaviors observed during striatal 
activation. Furthermore, exposure-based behavioral treatment of 
OCD can be linked to the process of extinction in the classical fear 
conditioning paradigm.
In our previous review,10 the most consistent finding in quantitative 
neuroimaging studies of PD was the reduced volume of the 
temporal lobe.64-66 Thus far, only two studies have been published 
confirming this reduction.68 The more recent studies included new 
anatomical regions, often by means of the VBM technique that 
allowed the investigation of differences in regional volumes along 
the whole brain.83 Thus, reductions of the anterior cingulate cortex, 
amygdala and hippocampal region have been described, as well as 
an increase in gray matter in the insula, superior temporal gyrus 
and the brain stem structures. The insula and anterior cingulate 
abnormalities may be particularly important to the pathophysiology 
of PD, since these structures participate in the evaluation process 
of negative emotional meaning to potentially distressing cognitive 
and interoceptive sensory information. On the other hand, the 
abnormal brain stem structures may be involved in the generation 
of panic attacks.83
Recent findings suggestive of a smaller volume of the putamen in 
patients with PD should also be pointed out, this being an area of the 
basal ganglia that has also been correlated with the severity of panic 
symptoms. In general, there is some degree of discrepancy between 
the findings of the various morphometric MRI studies of PD reported 
to date. Such variability of findings is possibly due to the different 
techniques of evaluation, the presence of co-morbidities among the 
subjects studied and the small number of participants in the majority 
of investigations. However, another reason for the discrepant results 
may also be the multiplicity of brain regions that may be involved 
in the pathophysiology of PD. In contemporary anatomic models 
of PD, it is proposed that panic attacks may be associated with 
abnormalities of brain stem regions. In addition, anticipatory anxiety 
may be related to abnormalities of limbic structures, while phobic 
avoidance may be related to abnormal activity of the temporal lobe, 
prefrontal cortical areas, and brain stem.84
Structural neuroimaging studies in the GAD are still in an early 
phase. The only report in the period reviewed in this article involved 
a highly heterogeneous sample,80 reflecting the methodological 
difficulty of conducting studies of this disorder in samples with a 
precise diagnosis and with no comorbidities. The detection of a 
reduction of the amygdala is in agreement with general theories that 
relate this region to the mechanisms of recognition and learning in 
threatening or dangerous situations.40,62
So far, only one structural neuroimaging study85 has evaluated 
the volume of brain structures in patients with SAD, as highlighted 
in our former review.10 In that ROI-based study, the authors found 
no differences between patients and healthy controls regarding the 
measures of the total brain, putamen, caudate, and thalamus.85 As 
our earlier observation,10 the present review notes the scarce number 
of morphometric MRI studies on SAD and specific phobias with 
no paper being published in the last five years in such disorders. 
Once again, it is surprising that SAD, one of the most frequent 
anxiety disorders in the general population which causes important 
functional impairments, was not investigated during this period. This 
is especially intriguing considering the relative easiness of recruiting 
never-medicated SAD patients and without significant co-morbidities 
during the initial phases of the disorder.86 
It is important to point out that the inconsistencies of structural 
imaging findings on the anxiety disorders reviewed in this paper 
do not reflect loss of validity of the model of investigation, but may 
rather reflect confounding factors resulting from the design of the 
studies. Many studies included subjects with co-morbidities such 
as depression or other anxiety disorders that might have hampered 
the specificity of the results. For example, hippocampal reduction, 
so frequently described in PTSD, is known to be associated with 
depressive signs and symptoms.87 Another important point is the 
inclusion of patients currently or previously taking medications since 
its use such as paroxetine, among others, has been shown to affect 
the cerebral morphology of the patients.35,59 Differences in age and 
in gender balancing also cause a lack of homogeneity between 
results. It is preferable to use only one gender or to have a balanced 
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gender proportion since there are specific gender-linked anatomical 
abnormalities that may have a negative influence on the results.88
An additional confounding factor is the presence of patients with 
different levels and types of symptoms. Regarding OCD in particular, 
a previous study suggested that the different symptomatologic 
dimensions such as contamination/washing and symmetry/
ordering may have distinct neural substrates.89 In agreement with 
this, several studies reviewed here confirmed correlations between 
the symptomatologic dimensions of OCD and specific structural 
abnormalities.53,54,57
In respect to the methods of MRI analysis, studies with automated 
analysis such as VBM hold the promise of capturing larger numbers 
of cerebral structures, thus reducing, for example, the difficulty of 
manual studies in delimiting the anatomical margins of the structure 
of interest and the problems of execution and reproducibility of this 
task. In the selected studies, analyses by VBM indeed accounted for 
the observation of changes in other cerebral structures not previously 
included as a  priori hypotheses in studies with ROI.21,29,33,36,37,72,73 
However, the diverse findings obtained in studies using this technique, 
in addition to sample differences, reveal that VBM still is an evolving 
method. There are limits regarding cerebral normalization and 
smoothing stages that may cause loss of information and degradation 
of anatomical details across different brain structures.90 Thus, it is 
necessary to determine whether the results obtained with VBM are 
comparable to those obtained with standard ROI-based morphometry, 
in order that the findings may be better analyzed in light of these 
methods, as recently conducted in a study in patients with PD.83
Also with respect to MRI methodologies, many studies have been 
carried out using 1.5 T scanners. However, 3.0 T (or stronger) 
scanners are increasingly available and may become the standard 
for research purposes in the next few years. Higher intensity 
magnets can enhance the signal-to-noise ratio in MRI, improving the 
distinctions between tissues. The extent to which these differences 
will impact on research in anxiety disorders should become clearer 
over the next decade.  
Of note, structural neuroimaging findings discussed in the present 
review are not readily reconcilable with the previous functional 
imaging literature on the anxiety disorders evaluated. For instance, 
in the MRI study by Choi et al.49 there was a reduction of the anterior 
region of the orbitofrontal cortex, whereas previous functional 
imaging studies demonstrated an increased activity of this region.91,92 
Moreover, increased activity of the orbitofrontal cortex, especially its 
anterior subregion, in functional imaging studies may be the result 
of compensatory hyperactivity of residual tissues secondary to 
decreased volume of this region.49 Another study93 reported increased 
gray matter density of left orbitofrontal cortex in patients with OCD 
using a VBM analysis. These observations suggest that increases 
in regional activity are not necessarily related to volume increases, 
and that decreases in activity are not necessarily related to volume 
decreases. In this respect, the structural studies can complement 
functional ones, especially regarding the delimitation of anatomical 
changes, the ability to show that increased or reduced tissue 
volumes are compatible with hypermetabolism due to compensatory 
mechanisms, and even the suggestion that brain abnormalities may 
vary progressively during the course of the disorders.53
Finally, it is equally important to acknowledge a cautionary note 
regarding whether these neuroimaging findings can be translated to 
clinical practice. The majority of neuroimaging studies in psychiatry 
are research-oriented, and are not designed to have an immediate 
clinical application. For instance, many neuroimaging findings relate 
to mean differences in comparisons between groups of patients and 
controls, and it is difficult to use this information in an individual 
patient in a clinical setting. Nevertheless, neuroimaging studies are 
increasingly being designed with the aim of translating findings into 
psychiatric practice, and neuroimaging is already playing a role in 
the diagnosis and management of dementia.94
Conclusion
The present review indicates that structural neuroimaging 
methods can be used for a better understanding of the neurobiology 
of anxiety disorders. Despite a few contradictory findings, mainly 
due to the variability and limitations of the methodologies used, 
morphometric abnormalities of some brain structures appear in a 
more consistent and relatively specific manner in certain anxiety 
disorders. In particular the hippocampus and anterior cingulate 
cortex are robustly implicated in PTSD and the orbitofrontal cortex 
has consistently been found to be the site of abnormalities in OCD. 
Apparently discrepant results may be due to the different a priori 
hypotheses used in studies with ROI, although the findings may 
indeed reveal distinct structures involved in the physiopathology of 
the same disorder. It will be important for future studies to reproduce 
prior findings and determine which findings are unique to early-
onset anxiety disorders, relative to adult-onset illness. Moreover, 
studies will need to establish the extent to which anxiety disorders 
may overlap with comorbid disruptive, mood, anxiety, or psychotic 
disorders. In addition, some diagnoses have been scarcely explored 
in the neuroimaging field. It is possible that the rapid advancement 
of neuroimaging techniques, a better sample standardization and 
greater emphasis on longitudinal studies will allow a clarification 
of this scenario.
Structural MRI in anxiety disorders
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